Pharmacy
Home Pharmacy
FDA Approves New Treatment for Acute Lymphoblastic Leukemia
For patients with relapsed or refractory B-cell ALL who have received one or two prior treatments
Declining COVID-19 Vaccination Rates Threaten Biden’s July 4 Goal
United States is averaging fewer than 1 million shots per day, a decline of more than two-thirds from a peak of 3.4 million in April
More Reassurance Against MMR-Autism Link
Finding held true even for children at risk for the developmental disorder
FDA Approves Sunlenca for Treatment-Resistant HIV
Sunlenca is the first capsid inhibitor approved for HIV
Fluorouracil Tied to Reduced Surgery for Squamous Cell CA
Reduced risk of squamous cell carcinoma, but not basal cell carcinoma, for one year in at-risk veterans
LDL-C Still High in Autosomal Recessive Hypercholesterolemia
Increase in use of high-intensity statin, ezetimibe; only 23.1 percent reach LDL-C of <100mg/dL
DEA Taking Back Unwanted Prescription Drugs on Oct. 28
Only pills or patches will be accepted, not liquids, needles, or sharps; service is free and anonymous
Rate of CVD Mortality, MI, Stroke Down for Patients on Semaglutide
Study confirms the noninferiority of semaglutide
Considerable Variation in Cost of Generic Topical Corticosteroids
Variation in cost seen across potencies, class, and by branded generic or generic product
